Examination Report |
1 | TM-1 | 27 Jan 2017 |
2 | Reply to Exam Report (MIS-R) | 27 Feb 2017 |
3 | Authorization Letter | 23 Oct 2019 |
4 | TM-M(CORRECTION OF CLERICAL ERROR OR FOR AMENDMENT U/R 37) | 25 Oct 2019 |
5 | Authorization Letter | 04 Dec 2019 |
6 | Documents in support of Show cause Hearing (SCH) | 16 Feb 2021 |
7 | Reply to Exam Report (MIS-R) | 09 Sep 2021 |
8 | Journal Copy | 26 Aug 2024 |
1 | Hearing Notice (Show Cause) | 8885560 | 4389919 | 06 Sep 2019 |
2 | Hearing notice (Adjourned) | 9643434 | 4762851 | 25 Jan 2020 |
3 | Hearing Notice (Show Cause) | 10662135 | 09 Nov 2020 | |
4 | Hearing Notice (Show Cause) | 10922020 | 06 Jan 2021 | |
5 | Hearing Notice (Show Cause) | 11607417 | 07 Jun 2021 | |
6 | EXAMINATION REPORT | 11964683 | 08 Aug 2021 | |
7 | Acceptance Order | 18625515 | 02 Aug 2024 |
The application for Tg pure was made on 27 January 2017.
The trademark applicant for Tg pure is AKUMS DRUGS PHARMACEUTICALS.
Tg pure is applied in class(es) 5.
Application for Tg pure is on Accepted & Advertised stage.
Application Id allotted to Tg pure is 3468043.
Tg pure filed with the Intellectual property office as a WORD.